Argenx: Myositis expert call invite: Wednesday 15th July 3-4pm UK [10-11am ET]

Research evidence excerpt

Argenx: Myositis expert call invite: Wednesday 15th July 3-4pm UK [10-11am ET]

Deutsche Bank

Research

Rating Company Date

Buy Argenx 25 June 2026

Company Update

Europe

Netherlands

Reuters Bloomberg Exchange Ticker Price at 24 Jun 2026 (EUR) 748.60

ARGX.BR ARGX BB BRU ARGX

Price Target (EUR) 750.00

Pharmaceuticals

813.00 -

Pharmaceuticals 52-week range (EUR) 460.40

Myositis expert call invite: Wednesday

Valuation & Risks 15th July 3-4pm UK [10-11am ET]

Emmanuel Papadakis, Ph.D., CFA

Myositis expert call: 15th July (15:00-16:00 UK [10:00-11:00 ET]) Research Analyst

As part of our expert call series, we will be hosting a myositis-focused expert call +44-20-754-18522

on Wednesday, 15th July, from 15:00–16:00 UK time [10:00-11:00 ET], to discuss

Niall Alexander

current treatment practice and upcoming late-stage data in idiopathic Research Analyst

inflammatory myopathies (IIM). +44-20-754-12185

Shashindra Seresinhe

The call will focus on expectations ahead of Argenx’s P3 ALKIVIA readout in

Research Associate

myositis, expected in Q3 2026, including discussion of the FcRn mechanism,

patient selection, positioning versus existing standards of care, and potential

implications for clinical practice across key IIM subtypes. We will also place Supun Ukwatta

ALKIVIA in the broader myositis competitive landscape, touching on other late- Research Associate

stage and emerging approaches and how clinicians are thinking about sequencing

and unmet need. Henrietta Boeg

Investors will have the opportunity to ask questions live during the call, or +44-20-754-10119

alternatively submit questions to the team in advance. We expect this call to be of Kate Farrelly

interest to investors following ARGX as well as broader immunology and Research Associate